Can scans predict breast cancer treatment success? new study aims to find out

NCT ID NCT06879704

First seen Jan 11, 2026 · Last updated Apr 28, 2026 · Updated 13 times

Summary

This study looks at 115 people with triple-negative breast cancer who are getting chemotherapy plus immunotherapy before surgery. Researchers want to see which imaging method—ultrasound, mammogram, MRI, or PET-CT—best predicts whether the cancer is completely gone after treatment. They also hope to find blood markers that show who will benefit most or face side effects. The goal is to personalize future care.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TRIPLE NEGATIVE BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Centre Henri Becquerel

    RECRUITING

    Rouen, 76038, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.